Christine Brennan

Vertex Ventures HC thesis

Boundless Bio develops ecDNA-directed therapies (ecDTx) intended to transform the lives of patients with aggressive gene amplified cancers Previous Next Redona Therapeutics targets nucleic acid process and sensing enzymes to address challenging diseases including cancer Previous Next Palleon Pharmaceuticals targets the glycan-sensing checkpoints to unleash both innate and adaptive immune response to cancer Previous Next Matchpoint Therapeutics discovers precision covalent medicines to transform the treatment of immune diseases and other serious illnesses Previous Next Sonoma Biotherapeutics cr

Sector and stage focus

• Seed: Medical Devices, Pharmaceuticals, BioTech, Health IT, Digital Health, Health & Hospital Services
• Series B: BioTech, Medical Devices, Pharmaceuticals, Health & Hospital Services, Digital Health, Health IT
• Series A: Medical Devices, BioTech, Pharmaceuticals, Health IT, Health & Hospital Services, Digital Health
• general: Boston / New England

Is Christine Brennan a fit for your round?

Upload your pitch deck and see whether Christine Brennan appears in your top 20 matches.